益智仁, 杜沖, 白殭蠶 혼합추출물이 남성갱년기 증상 개선에 미치는 영향
Effects of Fructus Amomi Amari, Eucommiae Cortex, Bombyx Batryticatus Extract on Improving Symptoms of Late-onset Hypogonadism
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
In recent times, the number of men with late-onset hypogonadism has increased, and interest on this topic has also increased. This study was conducted to investigate effects of the mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus on improve late-onset hypogonadism. The experimental subjects consisted of three groups: a control group consisting of 8-week-old male ICR mice that had undergone no treatment, an aging-elicited group (AE group) consisting of 50—week-old ICR male mice that had undergone no treatment, and a Mixed herbal extract treatment group (MT group) consisting of 50-week-old ICR male mice that had undergone the mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus treatment (0.1 g/kg/day) for 6 months. After the experiment, the mice from all the experimental groups were dissected, and they were analyzed through histochemical and immunohistochemical methods. The mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus reduces aging-induced cell damage and oxidative stress and increases the secretion of serotonin and B-endorphin in aged mice, and promotes spermatogenesis in seminiferous tubules and reduces apoptosis and oxidative stress, and increases androgen receptor, 17β-HSD and GnRH, increases the ratio of smooth muscle to collagen fibers in the corpus cavernosum, increases eNOS, decreases PDE-5 and oxidative stress in aged mice, so it improves depression, reproductive, sexual problems caused by Late-onset hypogonadism. the mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus inhibits the induction of osteoporosis by increasing decreased bone matrix distribution due to aging, increasing the activities of OPC and OPN, which are produced in osteoblasts, and decreasing RANKL, MMP-3 activity, increasing OPG activity. It also reduces muscle damage, oxidative stress, inflammation and apoptosis of muscle tissue, and increases Myo-D in the sartorius muscle of aged mice for improving muscle atrophy caused by by Late-onset hypogonadism.
Abstract
In recent times, the number of men with late-onset hypogonadism has increased, and interest on this topic has also increased. This study was conducted to investigate effects of the mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus on improve late-onset hypogonadism. The experimental subjects consisted of three groups: a control group consisting of 8-week-old male ICR mice that had undergone no treatment, an aging-elicited group (AE group) consisting of 50—week-old ICR male mice that had undergone no treatment, and a Mixed herbal extract treatment group (MT group) consisting of 50-week-old ICR male mice that had undergone the mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus treatment (0.1 g/kg/day) for 6 months. After the experiment, the mice from all the experimental groups were dissected, and they were analyzed through histochemical and immunohistochemical methods. The mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus reduces aging-induced cell damage and oxidative stress and increases the secretion of serotonin and B-endorphin in aged mice, and promotes spermatogenesis in seminiferous tubules and reduces apoptosis and oxidative stress, and increases androgen receptor, 17β-HSD and GnRH, increases the ratio of smooth muscle to collagen fibers in the corpus cavernosum, increases eNOS, decreases PDE-5 and oxidative stress in aged mice, so it improves depression, reproductive, sexual problems caused by Late-onset hypogonadism. the mixture extract of Fructus amomi Amari, Eucommiae cortex, Bombyx batryticatus inhibits the induction of osteoporosis by increasing decreased bone matrix distribution due to aging, increasing the activities of OPC and OPN, which are produced in osteoblasts, and decreasing RANKL, MMP-3 activity, increasing OPG activity. It also reduces muscle damage, oxidative stress, inflammation and apoptosis of muscle tissue, and increases Myo-D in the sartorius muscle of aged mice for improving muscle atrophy caused by by Late-onset hypogonadism.
참고문헌 (57)
- Araujo AB, "Prevalence of symptomatic androgen deficiency in men", J Clin Endocrinol Metab, 92(11), pp.4241~4247 (2007)
- Morales A, "Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male", Aging Male, 5(2), pp.74~86 (2002)
- Nieschlag E, "Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations", J Androl, 27(2), pp.135~137 (2006)
- Nieschlag E, "Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations", Eur Urol, 48(1), pp.1~4 (2005)
- Nieschlag E, "Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations", Int J Androl, 28(3), pp.125~127 (2005)
- Lunenfeld B, "ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale", Aging Male, 8(2), pp.59~74 (2005)
- Werner AA, "The male climacteric", J Am Med Assoc, 132, pp.188~194 (1946)
- 민권식, "남성갱년기 환자의 약물치료와 추적관찰", 대한의사협회지, 54(2), pp.197~204 (2011), 대한의사협회
- Calof OM, "Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials", J Gerontol A Biol Sci Med Sci, 60(11), pp.1451~1457 (2005)
- Bhasin S, "Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 95(6), pp.2536~2559 (2010)
- Wang C, "Gooren LJ, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males", Aging Male, 12(1), pp.5~12 (2009)
- Bhasin S, "Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 95(6), pp.2536~2559 (2010)
- Lee KW, "Huangjenaegyeongsomun", pp.31~38 (2001), Yeogang press
- 박선영, "益智仁의 음경해면체 평활근 이완효과", 대한본초학회지, 30(4), pp.71~79 (2015), 대한본초학회
- 박선영, "杜冲의 토끼 음경해면체 평활근 이완효과", 동의생리병리학회지, 29(6), pp.485~491 (2015), 한의병리학회[DOI]
- Wang YS, "Pharmacological applications of chinese medicine", pp.485~486 (1983), People’s medical publishing house
- Whang KT, "Effect of Batryticatus bombycis on the cerebral hemodynamics of rats", KOMP, 7(2), pp.121~130 (1999)
- Kim JJ., "Andropause", KU today, (autumn), pp.32~33 (2003)
- Diamond J., "Male menopause" (1997), Sourcebooks
- Shores MM, "Testosterone, aging and survival: biomarker or deficiency", Curr Opin Endocrinol Diabetes Obes, 21(3), pp.209~216 (2014)
- Juul A, "Androgens and the ageing male", Hum Reprod Update, 8(5), pp.423~433 (2002)
- Kabir MR, "Andropause : The Male Climacterium", TAJ, 21(1), pp.87~92 (2008)
- Gray A, "Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study", J Clin Endocrinol Metab, 73(5), pp.1016~1025 (1991)
- Harman SM, "Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging", J Clin Endocrinol Metab, 86(2), pp.724~731 (2001)
- Gruenewald DA, "Testosterone supplementation therapy for older men: potential benefits and risks", J Am Geriatr Soc, 51(1), pp.101~115 (2003)
- Rhoden EL, "Risks of testosterone- replacement therapy and recommendations for monitoring", N Engl J Med, 350(5), pp.482~492 (2004)
- Muller M, "Endogenous sex hormones and cardiovascular disease in men", J Clin Endocrinol Metab, 88(11), pp.5076~5086 (2003)
- 이경수, "호로파와 야관문 복합추출물의 남성갱년기 개선에 관한 연구", 한국식품과학회지, 47(4), pp.492~498 (2015), 한국식품과학회[DOI]
- 김태묵, "In-vitro와 In-vivo에서 산수유의 남성갱년기 개선효과", 생약학회지, 47(3), pp.264~272 (2016), 한국생약학회
- 이학수, "흰민들레 발효추출물의 남성 갱년기 개선에 대한 효과", 생명과학회지, 26(9), pp.1063~1073 (2016), 한국생명과학회
- Shin MK, "Clinical Herbology", pp.224~225 (2002), Younglim press
- Heo J., "Donguibogam", pp.741~ (1966), Namsandang
- Ho SR., "Local medicine of Chinese", pp.270~273 (1989), Heilongjiang science and technology press
- Lee SJ, "Bonchogangmok", pp.1986~1987 (1982), People’s medical publishing house
- Shin MK., "Clinical traditional herbology", pp.663~664 (1992), Younglim press
- Kim CM, "The encyclopedia of oriental herbal medicine", pp.2015~2019 (1998), Jungdam books
- 이진규, "급성 알코올 중독 어린 흰쥐의 해마 치상회에서 용담추출물이 신경세포생성과 세포사멸에 미치는 영향", 동의신경정신과학회지, 21(2), pp.29~44 (2010), 대한한방신경정신과학회
- Lorenzetti V, "Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies", J Affect Disord, 117(1-2), pp.1~17 (2009)
- McKinnon MC, "A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder", J Psychiatry Neurosci, 34(1), pp.41~54 (2009)
- 어진원, "생쥐 정소에서 비스페놀 에이 (Bisphenol A)가 Leydig cell의 유전자 발현과 세포자멸사에 주는 영향", Clinical and Experimental Reproductive Medicine, 35(3), pp.181~191 (2008), 대한생식의학회
- Valko M, "Free radicals and antioxidants in normal physiological functions and human disease", Int J Biochem Cell Biol, 39(1), pp.44~84 (2007)
- Valko M, "Free radicals, metals and antioxidants in oxidative stress-induced cancer", Chem Biol Interact, 160(1), pp.1~40 (2006)
- Berger M, "The expanded biology of serotonin", Annu Rev Med, 60, pp.355~366 (2009)
- Bloom FE, "Neuropeptides", Sci Am, 245(4), pp.148~168 (1981)
- Restak R., "The mind", pp.275~314 (1988), Bantam Books
- Gazouli M, "Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha", Endocrinology, 143(7), pp.2571~2583 (2002)
- Meroni SB, "Regulation of rat sertoli cell function by FSH: possible role of phosphatidylinositol 3-kinase", protein kinase B pathway, 2002, pp.174(2), 195~204
- Labrie F, "The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology", Steroids, 62(1), pp.148~158 (1997)
- 김지향, "Bisphenol A에 의한 Sertoli 세포주 내 세포자연사 검정", 발생과 생식, 9(2), pp.115~121 (2005), 한국발생생물학회
- Palmer RM, "Vascular endothelial cells synthesize nitric oxide from L-arginine", Nature, 333(6174), pp.664~666 (1988)
- Cirino G, "Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function", Proc Natl Acad Sci U S A, 100(9), pp.5531~5536 (2003)
- Kasugai S, "Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype", J Cell Physiol, 147(1), pp.111~120 (1991)
- Delmas PD, "Biochemical markers of bone turnover", J Bone Miner Res, 8(Suppl 2), pp.S549~S555 (1993)
- Jones DH, "Role of RANKL and RANK in bone loss and arthritis", Ann Rheum Dis, 61(Suppl 2), pp.ii32~ii39 (2002)
- McClung M, "Role of RANKL inhibition in osteoporosis", Arthritis Res Ther, 9(Suppl 1), pp.S3~ (2007)
- Woessner JF Jr, "Role of metalloproteinases in human osteoarthritis", J Rheumatol Suppl, 27, pp.99~101 (1991)
- Brack AS, "Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy", J Cell Sci, 118(Pt 20), pp.4813~4821 (2005)